new data findings/day
patient tests analyzed
Access over 40 genomic, clinical and pharmaceutical databases updated weekly by hundreds of expert curators.
Enrich your NGS analysis and interpretations with cutting-edge bioinformatics software solutions trusted by thousands worldwide.
Make improvements in life possible by partnering with one bioinformatics software provider empowering you from Sample to Insight.
Whole-exome sequencing (WES) using next-generation sequencing (NGS) technology is a powerful tool fo...
Next-generation sequencing (NGS) techniques allow high-throughput detection of a vast amount of gene...
Hint: The secret is in the biological context Today's discovery scientists are challenged with iden...
The Winter 2020 Release of the Human Gene Mutation Database (HGMD) Professional is available, expand...
Check out the new features of QIAGEN CLC Genomics Are you struggling to find a bioinformatics analy...
Using the Interactive Filter Cascade in QCI Interpret Translational
Overcoming Challenges in Variant Filtering and Prioritization
The key to target and biomarker discovery
HGMD Professional 2020.4 Release
Learn what's new in the QIAGEN CLC Genomics version 21 (v21) release
Targeted NGS panels and optimized analysis and interpretation bioinformatics software tools.
Discovery Bioinformatics Services is a reliable and convenient way to extend your in-house resources with expertise and perfectly tailored bioinformatics software and services that ensure high-quality results.
Enabling pharma companies to develop biomarker diagnostics and targeted therapies using real-world insights from oncology patient genomic data.
Helping clinical testing laboratories leverage the benefits of automation and expert support to improve test turnaround times, enhance clinical reporting capabilities and scale for future growth.
Join us at an event or attend a webinar to learn how our products, solutions and services are empowering customers around the world to unlock valuable molecular insights.
Çukurova University in Adana, Turkey, analyzes the ancient origins of rare genetic diseases
Scientists at the University of Washington develop new Ebola model and find clues to genetics of host resistance
Mount Sinai identifies a novel prognostic biomarker associated with treatement response in ovarian cancer patients